Gennadios Aristippos

Avg. Two Year Performance

No purchase track record
1% Avg. Sale Return
1% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%< 1%3%2%1%
Sale Success Rate1 of 71 of 71 of 71 of 71 of 7

Catalent, Inc.

Drugs » Drugs - Generic

Group Pres. Pharma & Consumer:

Holdings: 113.72K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--